The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(benzyloxy)-5-(4-hydroxystyryl)phenol ID: ALA5287750
Chembl Id: CHEMBL5287750
Max Phase: Preclinical
Molecular Formula: C21H18O3
Molecular Weight: 318.37
Associated Items:
Names and Identifiers Canonical SMILES: Oc1ccc(/C=C/c2cc(O)cc(OCc3ccccc3)c2)cc1
Standard InChI: InChI=1S/C21H18O3/c22-19-10-8-16(9-11-19)6-7-18-12-20(23)14-21(13-18)24-15-17-4-2-1-3-5-17/h1-14,22-23H,15H2/b7-6+
Standard InChI Key: DQRVEESLGDZHMJ-VOTSOKGWSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 318.37Molecular Weight (Monoisotopic): 318.1256AlogP: 4.85#Rotatable Bonds: 5Polar Surface Area: 49.69Molecular Species: NEUTRALHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.63CX Basic pKa: ┄CX LogP: 5.27CX LogD: 5.25Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.66Np Likeness Score: 0.26
References 1. Ahmadi R, Ebrahimzadeh MA.. (2020) Resveratrol - A comprehensive review of recent advances in anticancer drug design and development., 200 [PMID:32485531 ] [10.1016/j.ejmech.2020.112356 ]